Patients arriving with suspected stroke also comprise most cases presenting in the 3-hour window for intravenous tissue plasminogen activator (IV t-PA), the only Food and Drug Administration–approved treatment of acute ischemic stroke (3,7). Here, PLAT is linked to stroke disorder.